Debu Tripathy

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi request reprint Awareness, concern, and communication between physicians and patients on bone health in cancer
    Debu Tripathy
    USC Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave, 3447, Los Angeles, CA, 90033, USA
    Support Care Cancer 22:1601-10. 2014
  2. pmc First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER
    Debu Tripathy
    University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles, California 90033, USA
    Oncologist 18:501-10. 2013
  3. pmc Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
    Hope S Rugo
    University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143 1710, USA
    Breast Cancer Res Treat 141:461-70. 2013
  4. pmc The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Debu Tripathy
    Keck School of Medicine, University of Southern California, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA
    BMC Cancer 14:307. 2014
  5. pmc Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2
    Nyam Osor Chimge
    Department of Biochemistry and Molecular Biology, Keck School of Medicine of the University of Southern California, 2250 Alcazar Street, Los Angeles, CA 90033, USA
    Breast Cancer Res 13:R127. 2011

Detail Information

Publications5

  1. ncbi request reprint Awareness, concern, and communication between physicians and patients on bone health in cancer
    Debu Tripathy
    USC Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave, 3447, Los Angeles, CA, 90033, USA
    Support Care Cancer 22:1601-10. 2014
    ..This study aims to explore physician-patient communications about bone metastases and cancer treatment-induced bone loss (CTIBL)...
  2. pmc First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER
    Debu Tripathy
    University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles, California 90033, USA
    Oncologist 18:501-10. 2013
    ..We examined first-line treatment patterns and clinical outcomes in patients with HER2-positive, HR-positive MBC in a real-world setting...
  3. pmc Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
    Hope S Rugo
    University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143 1710, USA
    Breast Cancer Res Treat 141:461-70. 2013
    ..Further research is needed to identify potential biologic differences that could have predictive impact for black patients or that could explain these differences. ..
  4. pmc The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Debu Tripathy
    Keck School of Medicine, University of Southern California, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA
    BMC Cancer 14:307. 2014
    ....
  5. pmc Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2
    Nyam Osor Chimge
    Department of Biochemistry and Molecular Biology, Keck School of Medicine of the University of Southern California, 2250 Alcazar Street, Los Angeles, CA 90033, USA
    Breast Cancer Res 13:R127. 2011
    ..We asked whether the beneficial effect of estrogen signaling in late-stage BCa is attributable to the recently reported estrogen-mediated antagonism of the pro-metastatic transcription factor Runx2...